Biological effects of IL-15 on immune cells and its potential for the treatment of cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological effects of IL-15 on immune cells and its potential for the treatment of cancer
Authors
Keywords
IL-15, Cytokine, Tumor microenvironment, Superagonist, Cancer
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 91, Issue -, Pages 107318
Publisher
Elsevier BV
Online
2020-12-29
DOI
10.1016/j.intimp.2020.107318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The construction of a new oncolytic herpes simplex virus expressing murine interleukin‐15 with gene‐editing technology
- (2020) Linkang Cai et al. JOURNAL OF MEDICAL VIROLOGY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer
- (2020) Xin Zhang et al. Frontiers in Immunology
- Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
- (2020) Giulia Gionfriddo et al. Cells
- Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells
- (2020) Tamio Okimoto et al. CANCER SCIENCE
- CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
- (2020) Margery Gang et al. BLOOD
- Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
- (2020) Estefanía Paula Juliá et al. Cells
- Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
- (2020) Andras Heczey et al. NATURE MEDICINE
- Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15
- (2019) Junlin Yao et al. Journal for ImmunoTherapy of Cancer
- Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
- (2019) Karin M. Knudson et al. Journal for ImmunoTherapy of Cancer
- IL-15-mediated reduction of mTORC1 activity preserves the stem cell memory phenotype of CAR-T cells and confers superior antitumor activity
- (2019) Darya Alizadeh et al. Cancer Immunology Research
- Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model
- (2019) Hideki Furuya et al. Journal of Translational Medicine
- Roles of NKT cells in cancer immunotherapy
- (2019) Eun-Ah Bae et al. ARCHIVES OF PHARMACAL RESEARCH
- IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion
- (2019) Kevin C Conlon et al. CLINICAL CANCER RESEARCH
- The role of cytokines in the regulation of NK cells in the tumor environment
- (2019) Gordana M. Konjević et al. CYTOKINE
- Oxidative stress-induced IL-15 transtrans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo
- (2019) Xuguang Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck
- (2019) Ashley Pinette et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treatment with Recombinant Interleukin-15 (IL-15) Increases the Number of T Cells and Natural Killer (NK) Cells and Levels of Interferon-γ (IFN-γ) in a Rat Model of Sepsis
- (2019) Xianyuan Zhao et al. MEDICAL SCIENCE MONITOR
- NKT cells co-expressing a GD2-specific chimeric antigen receptor and IL-15 show enhanced in vivo persistence and antitumor activity against neuroblastoma
- (2019) Xin Xu et al. CLINICAL CANCER RESEARCH
- Highly Selective Cleavage of TH2-Promoting Cytokines by the Human and the Mouse Mast Cell Tryptases, Indicating a Potent Negative Feedback Loop on TH2 Immunity
- (2019) Zhirong Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
- (2019) Backhaus et al. Viruses-Basel
- JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
- (2019) Dagmar Gotthardt et al. Frontiers in Immunology
- Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
- (2019) Thomas A. Waldmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Control of memory CD8+ T cell longevity and effector functions by IL-15
- (2019) Jeffrey C. Nolz et al. MOLECULAR IMMUNOLOGY
- The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
- (2019) Annekathrin Heinze et al. Frontiers in Immunology
- Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
- (2019) Alexandra Berger et al. Journal for ImmunoTherapy of Cancer
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression
- (2018) Rika Fujii et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia
- (2018) M. Vela et al. CANCER LETTERS
- Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
- (2018) Cristina Bergamaschi et al. CYTOKINE
- Soluble γc receptor attenuates anti-tumor responses of CD8+ T cells in T cell immunotherapy
- (2018) Geona Kim et al. INTERNATIONAL JOURNAL OF CANCER
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- Superagonist IL-15-armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
- (2018) Stacy J. Kowalsky et al. MOLECULAR THERAPY
- TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival
- (2018) Lele Zhu et al. Nature Communications
- Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy
- (2018) Qiyue Hu et al. Scientific Reports
- Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion
- (2018) Heleen H. Van Acker et al. Frontiers in Immunology
- The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells
- (2018) Yufeng Wang et al. NATURE IMMUNOLOGY
- IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses
- (2018) Rosa M. Santana Carrero et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
- (2018) Meili Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy
- (2017) Xilong Wu et al. JOURNAL OF CONTROLLED RELEASE
- IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56 bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
- (2017) Sigrid Dubois et al. Cancer Immunology Research
- Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15
- (2017) Maria Carmen Ochoa et al. OncoImmunology
- Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
- (2017) Robert J. Canter et al. Journal for ImmunoTherapy of Cancer
- IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells
- (2016) Y. Mao et al. BLOOD
- IL-15/sIL-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys
- (2016) H Sun et al. CANCER GENE THERAPY
- Systematic review of case reports on the abscopal effect
- (2016) Yazan Abuodeh et al. CURRENT PROBLEMS IN CANCER
- Phase Ib trial of ALT-803, an IL-15 superagonist, plus Bacillus Calmette Guerin (BCG) for the treatment of patients with BCG-naïve non-muscle-invasive bladder cancer (NMIBC).
- (2016) Charles Joel Rosser et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
- (2016) Heleen H. Van Acker et al. Journal of Hematology & Oncology
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
- (2016) Nathan Singh et al. Science Translational Medicine
- The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
- (2015) M. Rosario et al. CLINICAL CANCER RESEARCH
- A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors
- (2015) Antonio Pérez-Martínez et al. CYTOTHERAPY
- Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
- (2015) Dimitrios Mathios et al. INTERNATIONAL JOURNAL OF CANCER
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells
- (2015) Patricia K. A. Mongini et al. JOURNAL OF IMMUNOLOGY
- The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy
- (2015) T. A. Waldmann Cancer Immunology Research
- IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity
- (2015) Rajia Bahri et al. OncoImmunology
- Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity
- (2015) Karsten Pilones et al. Journal for ImmunoTherapy of Cancer
- Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
- (2014) V. Bachanova et al. BLOOD
- Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
- (2014) A. Mishra et al. CLINICAL CANCER RESEARCH
- IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells
- (2014) Aparna R. Shenoy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Critical Role of IL-15 in the Antitumor Effects Mediated by the Combination Therapy Imatinib and IL-2
- (2014) G. Mignot et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Tumor Growth by NK1.1+ Cells and CD8+ T Cells Activated by IL-15 through Receptor /Common Signaling in trans
- (2014) J. Rowley et al. JOURNAL OF IMMUNOLOGY
- Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
- (2014) Evan Gomes-Giacoia et al. PLoS One
- Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
- (2014) Vesna Tosic et al. PLoS One
- Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
- (2014) B. Mlecnik et al. Science Translational Medicine
- Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy
- (2013) E. Laprevotte et al. JOURNAL OF IMMUNOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
- (2012) N. Cieri et al. BLOOD
- IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
- (2012) María P. Roberti et al. BREAST CANCER RESEARCH AND TREATMENT
- Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation
- (2012) Anjali Mishra et al. CANCER CELL
- IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
- (2012) Daofeng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-15 Can Signal via IL-15R , JNK, and NF- B To Drive RANTES Production by Myeloid Cells
- (2012) M. J. Chenoweth et al. JOURNAL OF IMMUNOLOGY
- Augmented IL-15R Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
- (2012) M. Zhang et al. JOURNAL OF IMMUNOLOGY
- Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
- (2012) P. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood
- (2011) M. C. Sneller et al. BLOOD
- Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression
- (2011) Esther Moga et al. EXPERIMENTAL HEMATOLOGY
- Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling
- (2011) G Epron et al. LEUKEMIA
- Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates
- (2010) E. Lugli et al. BLOOD
- Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells
- (2010) Nadine Pouw et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Activity of Recombinant Human Interleukin-15 against Tumor Recurrence and Metastasis in Mice
- (2010) Feng Tang et al. Cellular & Molecular Immunology
- Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
- (2010) P. Yu et al. CLINICAL CANCER RESEARCH
- Interleukin-15 Enhances Proteasomal Degradation of Bid in Normal Lymphocytes: Implications for Large Granular Lymphocyte Leukemias
- (2009) D. L. Hodge et al. CANCER RESEARCH
- Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis
- (2009) Jesse Rowley et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8+ T Cell Subsets
- (2009) Erwan Mortier et al. IMMUNITY
- IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
- (2009) M. B. Ahmed et al. JOURNAL OF IMMUNOLOGY
- IL-15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3
- (2008) Hiromi Imamichi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways
- (2007) D. de Totero et al. BLOOD
- NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma
- (2007) Esther Moga et al. EXPERIMENTAL HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now